Novartis AG (NVS)
NYSE: NVS
· Real-Time Price · USD
124.19
2.10 (1.72%)
At close: Aug 15, 2025, 3:59 PM
124.00
-0.15%
After-hours: Aug 15, 2025, 07:33 PM EDT
Novartis Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.66B | 7.07B | 11.46B | 13.61B | 7.9B | 9.47B | 13.39B | 12.4B | 10.88B | 12B | 7.52B | 8.73B | 3.63B | 13.85B | 12.41B | 7.21B | 5.12B | 3.8B |
Short-Term Investments | 344M | 130M | 1.89B | 411M | 532M | 225M | 569M | 290M | 289M | 260M | 11.41B | 10.38B | 16.13B | 4.96B | 15.92B | 951M | 239M | 276M |
Long-Term Investments | 2.16B | 2.1B | 1.13B | 2.19B | 2.13B | 2.58B | 1.83B | 2.12B | 2.43B | 2.56B | 2.55B | 2.49B | 2.58B | 2.91B | 3.24B | 12.35B | 12.01B | 11.63B |
Other Long-Term Assets | 4.47B | 4.11B | 4.51B | 1.39B | 1.66B | 1.21B | 2.18B | 1.11B | 1.21B | 1.21B | 1.11B | 3.19B | 3.88B | 3.86B | 2.21B | 2.13B | 2.21B | 1.59B |
Receivables | 9.18B | 8.72B | 8.21B | 8.15B | 8.48B | 8.25B | 8.12B | 7.1B | 9.54B | 9.18B | 8.94B | 8.68B | 8.91B | 8.68B | 8.83B | 8.63B | 8.65B | 8.48B |
Inventory | 6.31B | 5.83B | 5.72B | 5.94B | 5.75B | 5.74B | 5.91B | 5.61B | 8.23B | 7.89B | 7.17B | 6.78B | 6.88B | 7B | 6.67B | 6.88B | 7.11B | 7B |
Other Current Assets | 3.46B | 3.36B | 1.43B | 3.15B | 3.03B | 2.7B | 2.62B | 20.26B | 4.55B | 2.79B | 2.03B | 2.39B | 2.59B | 2.75B | 1.72B | 2.57B | 2.69B | 2.64B |
Total Current Assets | 25.94B | 25.11B | 29.7B | 31.26B | 25.69B | 26.45B | 30.48B | 45.66B | 33.49B | 32.11B | 36.91B | 36.95B | 38.14B | 37.24B | 45.72B | 26.25B | 23.81B | 22.2B |
Property-Plant & Equipment | 11.83B | 11.09B | 10.87B | 11.2B | 10.62B | 10.54B | 10.92B | 10.34B | 12.28B | 12.35B | 12.2B | 11.73B | 12.21B | 12.86B | 13.11B | 13.16B | 13.34B | 13.2B |
Goodwill & Intangibles | 54.79B | 52.44B | 51.67B | 52.83B | 53.01B | 49.34B | 50.22B | 49.83B | 57.52B | 59.93B | 60.95B | 60.56B | 62.48B | 64.49B | 63.78B | 63.52B | 64.58B | 64.97B |
Total Long-Term Assets | 78.46B | 74.83B | 72.54B | 72.26B | 71.81B | 67.89B | 69.46B | 67.04B | 77.49B | 80.13B | 80.54B | 81.51B | 84.77B | 87.98B | 86.08B | 94.96B | 100.21B | 99.55B |
Total Assets | 104.39B | 99.94B | 102.25B | 103.52B | 97.5B | 94.33B | 99.94B | 112.7B | 110.98B | 112.24B | 117.45B | 118.46B | 122.91B | 125.22B | 131.79B | 121.21B | 124.02B | 121.75B |
Account Payables | 4.51B | 4.26B | 4.57B | 4.09B | 4.15B | 4.06B | 4.93B | 3.87B | 5.35B | 5.43B | 5.15B | 4.69B | 4.97B | 5.08B | 5.55B | 4.67B | 4.81B | 5.04B |
Deferred Revenue | n/a | n/a | 127M | n/a | 1.92B | 1.65B | 98M | 16.09B | 17.99B | n/a | 123M | n/a | n/a | n/a | 123M | 2.46B | -279M | -10.44B |
Short-Term Debt | 8.31B | 7.8B | 8.09B | 6.57B | 7.53B | 8.34B | 6.08B | 5.46B | 8.29B | 6.97B | 5.93B | 7.05B | 7.04B | 6.7B | 6.29B | 9.34B | 9.07B | 10.16B |
Other Current Liabilities | 15.81B | 16.75B | 10.38B | 15.07B | 13.78B | 15.01B | 10.83B | 36.73B | 34M | 17.9B | 12.35B | 16.16B | 15.37B | 17.76B | 13.29B | 13.14B | 15.47B | 14.68B |
Total Current Liabilities | 31.71B | 31.62B | 28.69B | 28.13B | 27.61B | 29.29B | 26.39B | 48.39B | 31.91B | 30.55B | 28.66B | 28.16B | 27.65B | 29.81B | 30.21B | 29.88B | 29.63B | 30.16B |
Long-Term Debt | 22.47B | 21.67B | 21.37B | 23.75B | 19.66B | 17.19B | 18.44B | 18.07B | 18.26B | 20.4B | 20.24B | 19.73B | 22.23B | 22.8B | 22.9B | 23.1B | 24.83B | 25.75B |
Other Long-Term Liabilities | 4.24B | 4.09B | 4.08B | 4.39B | 4.31B | 4.26B | 3.44B | 4.08B | 4.81B | 4.84B | 4.91B | 5.45B | 5.35B | 5.95B | 4.54B | 6.33B | 6.29B | 6.21B |
Total Long-Term Liabilities | 30.63B | 29.87B | 29.43B | 31.95B | 27.99B | 25.29B | 26.8B | 26.06B | 27.14B | 29.55B | 29.37B | 29.41B | 32.26B | 33.71B | 33.77B | 34.39B | 40.25B | 41B |
Total Liabilities | 62.34B | 61.49B | 58.12B | 60.08B | 55.6B | 54.58B | 53.2B | 74.45B | 59.05B | 60.1B | 58.03B | 57.57B | 59.9B | 63.51B | 63.97B | 64.27B | 69.89B | 71.16B |
Total Debt | 32.64B | 31.27B | 31.26B | 32.16B | 28.99B | 27.28B | 26.35B | 25.19B | 28.34B | 29.2B | 27.96B | 28.54B | 31.09B | 31.34B | 31.09B | 34.33B | 35.84B | 37.84B |
Common Stock | 766M | 766M | 793M | 793M | 793M | 793M | 825M | 825M | 842M | 842M | 890M | 890M | 890M | 901M | 901M | 901M | 913M | 913M |
Retained Earnings | 41.53B | 39.84B | n/a | 46.29B | 45.84B | 43.83B | 49.65B | 42.33B | 55.68B | 56.09B | 63.54B | 64.54B | 65.43B | 63.45B | 70.99B | 57.44B | 54.4B | 52.05B |
Comprehensive Income | -275M | -2.22B | -3.25B | -3.73B | -4.87B | -4.93B | 45.88B | -4.96B | 51.06B | 51.25B | 58.54B | 60B | 62.09B | 60.7B | 66.8B | 55.92B | 53.19B | 49.67B |
Shareholders Equity | 41.98B | 38.37B | 44.05B | 43.32B | 41.73B | 39.67B | 46.67B | 38.16B | 51.85B | 52.06B | 59.34B | 60.82B | 62.92B | 61.54B | 67.66B | 56.77B | 54.04B | 50.52B |
Total Investments | 2.5B | 2.23B | 3.02B | 2.6B | 2.66B | 2.81B | 2.4B | 2.41B | 2.72B | 2.81B | 11.24B | 12.87B | 18.71B | 7.87B | 17.97B | 13.3B | 12.25B | 11.9B |